Clinical Trial Update: [18F] F-GLN by PET/CT in Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the PET imaging tracer [18F] F-GLN for breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [18F] F-GLN

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING